Result of AGM

RNS Number : 2097E

Sareum Holdings PLC

16 December 2009

 

(AIM: SAR)

16 December 2009

SAREUM HOLDINGS PLC

("Sareum" or the "Company") 

Result of AGM

The Company announces that at the annual general meeting, held earlier today, all resolutions were duly passed.

Further to the announcement made on 19 October 2009, the Company confirms that its Nominated Adviser is Merchant John East Securities Limited and its broker is Hybridan LLP.

Enquires:

Sareum Holdings plc
Tim Mitchell	01223 497 700
Merchant John East Securities Limited (Nominated Adviser)
Simon Clements/Bidhi Bhoma	020 7628 2200
Hybridan LLP (Broker)
Claire Noyce/Stephen Austin	020 3159 5085

Notes for editors: 

About Sareum Holdings plc

Sareum is a drug discovery company, headquartered in Cambridge UK, that is focused on producing targeted small molecule therapeutics to address unmet medical needs, primarily in cancer.

Sareum aims to successfully deliver drug candidates for licensing to pharmaceutical and biotechnology companies at the pre-clinical or early clinical trials stage.

Sareum Holdings plc joined the AIM market of the London Stock Exchange in October 2004, trading under the symbol SAR. For further information, please visit www.sareum.co.uk

 

END

 

 

RAGCKAKKDBDDKBD